| ABXAbacus Global Management, Inc. |
235,2 mln USD |
15,5% |
2025 |
| ABXXFAbaxx Technologies Inc. |
b.d. |
b.d. |
b.d. |
| ABBVAbbVie Inc. |
61,2 mld USD |
6,9% |
2025 |
| ABTSAbits Group Inc |
9,1 mln USD |
-31,4% |
2025 |
| ABVXAbivax S.A. |
b.d. |
b.d. |
2025 |
| ABLVAble View Global Inc. |
105,2 mln USD |
0,8% |
2025 |
| AACOAbony Acquisition Corp. I |
b.d. |
b.d. |
b.d. |
| ABVEFAbove Food Ingredients Inc. |
b.d. |
b.d. |
b.d. |
| ABPOAbpro Holdings, Inc. |
b.d. |
b.d. |
2025 |
| ABSIAbsci Corp |
2,8 mln USD |
-4113,7% |
2025 |
| ASOAcademy Sports & Outdoors, Inc. |
6,1 mld USD |
6,2% |
2025 |
| ACHCAcadia Healthcare Company, Inc. |
3,3 mld USD |
-33,3% |
2025 |
| AAMIAcadian Asset Management Inc. |
563,7 mln USD |
14,2% |
2025 |
| ACELAccel Entertainment, Inc. |
1,3 mld USD |
3,9% |
2025 |
| ARXAccelerant Holdings |
912,9 mln USD |
-156,1% |
2025 |
| ACNAccenture plc |
74,2 mld USD |
11,3% |
2026 |
| ACCLAcco Group Holdings Ltd |
4,9 mln USD |
20,9% |
2025 |
| ASIIAccredited Solutions, Inc. |
688,9 tys. USD |
-216,1% |
2023 |
| ACUTAccustem Sciences Inc. |
b.d. |
b.d. |
2025 |
| ACONAclarion, Inc. |
75,7 tys. USD |
-9551,9% |
2025 |
| ACRSAclaris Therapeutics, Inc. |
7,8 mln USD |
-829,6% |
2025 |
| ACRVAcrivon Therapeutics, Inc. |
b.d. |
b.d. |
2025 |
| ATNMActinium Pharmaceuticals, Inc. |
90 tys. USD |
-37 652,2% |
2025 |
| AEAQActivate Energy Acquisition Corp. |
b.d. |
b.d. |
b.d. |
| ABOSAcumen Pharmaceuticals, Inc. |
b.d. |
b.d. |
2025 |
| ACXPAcurx Pharmaceuticals, Inc. |
b.d. |
b.d. |
2025 |
| GOLFAcushnet Holdings Corp. |
2,6 mld USD |
7,4% |
2025 |
| ADAGAdagene Inc. |
7,7 mln USD |
-229,6% |
2025 |
| ADGMAdagio Medical Holdings, Inc. |
0 USD |
b.d. |
2025 |
| AHCOAdaptHealth Corp. |
3,2 mld USD |
-2,2% |
2025 |
| ADTIAdapti, Inc. |
b.d. |
b.d. |
b.d. |
| ADAPYAdaptimmune Therapeutics PLC |
178 mln USD |
-39,8% |
2024 |
| ADPTAdaptive Biotechnologies Corp |
277 mln USD |
-21,5% |
2025 |
| ADOOYAdaro Energy PT |
b.d. |
b.d. |
b.d. |
| XTXXFAdastra Holdings Ltd. |
13,3 mln CAD |
-32,2% |
2022 |
| ADXNAddex Therapeutics Ltd. |
404,1 tys. CHF |
1746,0% |
2024 |
| ADDTFAddtech AB |
b.d. |
b.d. |
b.d. |
| ADUSAddus HomeCare Corp |
1,4 mld USD |
6,7% |
2025 |
| AGROAdecoagro S.A. |
1,5 mld USD |
6,1% |
2024 |
| ADEAAdeia Inc. |
443,4 mln USD |
25,1% |
2025 |
| ADIAAdia Nutrition, Inc. |
700,5 tys. USD |
-56,5% |
2025 |
| ACETAdicet Bio, Inc. |
b.d. |
b.d. |
2025 |
| ADNTAdient plc |
14,5 mld USD |
-1,9% |
2025 |
| ADTXAditxt, Inc. |
3,2 tys. USD |
-1 349 028,2% |
2025 |
| ANLAdlai Nortye Ltd. |
b.d. |
b.d. |
2024 |
| ADSEAds-Tec Energy Public Ltd Co |
110 mln € |
-89,0% |
2024 |
| ASIXAdvanSix Inc. |
1,5 mld USD |
3,2% |
2025 |
| ADVBAdvanced Biomed Inc. |
b.d. |
b.d. |
2025 |
| AFCGAdvanced Flower Capital Inc. |
24,6 mln USD |
-85,7% |
2025 |
| ADVAdvantage Solutions Inc. |
3,5 mld USD |
-6,4% |
2025 |